NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ
Post# of 73
(Total Views: 142)
Posted On: 05/19/2022 3:54:53 PM
NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate in H.C. Wainwright Global Hybrid Investment Conference
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, and its CEO Dr. Faz Chowdhury will be attending the upcoming H.C. Wainwright Global Hybrid Investment Conference. The conference is slated for May 23–26, 2022, in Miami Beach, Florida. Chowdhury has been invited to present during the event; his virtual presentation is slated for May 24, and will be available on demand beginning 7 a.m. ET. According to the company, Chowdhury’s presentation will include updates on recent business developments. Chowdhury will also be available for one-on-one meetings with investors.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, and its CEO Dr. Faz Chowdhury will be attending the upcoming H.C. Wainwright Global Hybrid Investment Conference. The conference is slated for May 23–26, 2022, in Miami Beach, Florida. Chowdhury has been invited to present during the event; his virtual presentation is slated for May 24, and will be available on demand beginning 7 a.m. ET. According to the company, Chowdhury’s presentation will include updates on recent business developments. Chowdhury will also be available for one-on-one meetings with investors.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Nemaura Medical Inc. (NMRD) Stock Research Links
Scroll down for more posts ▼